Predictive Oncology launched new AI platform for vaccine and drug development targeting coronaviruses and Acute Respiratory Syndromes
On Mar. 12, 2020, Predictive Oncology announced it will launch a new AI platform for vaccine and drug…
-
-
Qatar reported one confirmed case of Middle East Respiratory Syndrome Coronavirus infection
On May 12, 2022, the National IHR Focal Point for Qatar reported two laboratory-confirmed cases of Middle East…
-
Pluristem and Charit’ University of Medicine Berlin joinly target potential treatment for respiratory and inflammatory Intratissue complications caused by COVID-19
On Mar. 12, 2020, Pluristem Therapeutics announced it a collaborative agreement with the BIH Center for Regenerative Therapy…
-
Vir Biotec announced intent to collaborate with Biogen on manufacturing of antibodies to potentially treat COVID-19
On Mar. 12, 2020, Vir Biotech announced it had signed a letter of intent with Biogen for the…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | NIH | Non-Profit Research | Therapeutics
Emory University among U.S. sites to host clinical trial for COVID-19 treatment
On Mar. 12, 2020, Emory University announced it was participating in a National Institutes of Health (NIH) sponsored…
-
AbCellera and Eli Lilly to co-develop antibody therapies for treatment of COVID-19
On Mar. 12, 2020, AbCellera and Eli Lilly announced an agreement to co-develop antibody products for the treatment…
-
Mayo Clinic developed test to detect COVID-19 infection
On Mar. 12, 2020, the Mayo Clinic announced it had developed a test that can detect the SARS-CoV-2…
-
Emergent BioSolutions initiated development of product candidates for treatment of Coronavirus
On Mar. 11, 2020, Emergent BioSolutions announced it has initiated development of two product candidates for treatment and…
-
Vir Biotec announced research collaboration with NIH Vaccine Research Center on antibodies against coronaviruses
On Mar. 11, 2020, Vir Biotech announced a research collaboration agreement with the NIH to advance characterization and…
-
La Jolla Institute for Immunology identified potential targets for immune responses to novel coronavirus
On Mar. 11, 2020, the La Jolla Institute for Immunology (LJI) and the J. Craig Venter Institute announced…
-
World Health Organization declared the Coronavirus outbreak a global pandemic
On Mar. 11 2020, the World Health Organization declared the Coronavirus outbreak a global pandemic. To-date, of the…
-
Newer anti-HIV drugs safest, most effective during pregnancy
On Mar. 11, 2020, the antiretroviral drugs dolutegravir and emtricitabine/tenofovir alafenamide fumarate (DTG+FTC/TAF) may comprise the safest and…
-
HHMI announced $120 million program for medically trained scientists
On Mar. 11, 2020, the Howard Hughes Medical Institute (HHMI) announced a new investment of over $120 million…
-
First of 3 diagnostic tests for SARS-CoV-2 coronavirus available from bioMerieux
On Mar. 11, 2020, bioMerieux announced the forthcoming launch of 3 different tests to address the COVID-19 epidemic…
-
CaroGen and Yale scientists joined to develop a COVID-19 vaccine
On Mar. 10, 2020, CaroGen and scientists from Yale announced they had begun work on a vaccine targeting…
-
Bill & Melinda Gates Foundation, Wellcome, and Mastercard launched COVID-19 Therapeutics Accelerator
On Mar. 10, 2020, the Bill & Melinda Gates Foundation, Wellcome, and Mastercard committed up to $125 million…
-
U.S. Regional Biocontainment Lab to begin testing of Brilacidin against Coronavirus (COVID-19)
On Mar. 10, 2020, Innovation Pharma announced that management was advised that testing of Brilacidin, the Company’s flagship…
-
CerTest Biotec and BD announced COVID-19 diagnostic test
On Mar. 10, 2020, BCerTest Biotec, along with BD (Becton, Dickinson and Company) announced that the VIASURE SARS-CoV-2…
-
Biotechnology | Disease | FDA | Therapeutics
The FDA approved the first treatment for group of progressive interstitial lung diseases
On Mar. 9, 2020, The U.S. Food and Drug Administration (FDA) approved Ofev (nintedanib) oral capsules to treat…
-
Biotechnology | HIV | NIH | Therapeutics
Drug-delivery technology leads to sustained HIV antibody production in NIH study
On Mar. 9, 2020, researchers from the National Institute of Allergy and Infectious Diseases (NIAID), part of the…
-
NIHs Study found lower concentration of PrEP drug in young women during pregnancy than postpartum
On Mar. 9, 2020, among African adolescent girls and young women who took HIV pre-exposure prophylaxis (PrEP) daily,…
-
MediciNova announced plans to develop MN-166 (ibudilast) for severe pneumonia and ARDS
On Mar. 9, 2020, MediciNova announced that it planned to initiate development of MN-166 (ibudilast) for severe pneumonia…
-
Winship Cancer Institute’s multiple myeloma team awarded $5 million grant from the Leukemia & Lymphoma Society
On Mar. 9, 2020, Winship Cancer Institute’s multiple myeloma team was awarded a $5 million grant from The…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | NIH | Non-Profit Research | Therapeutics | U.S. Congress
Innovation Pharma Brilacidin received by US Regional Biocontainment Lab for testing against COVID-19
On Mar. 9, 2020, Innovation Pharmaceuticals announced it was notified by one of the 12 Regional Biocontainment Labs…
-
Ampligen to be tested by Japan’s National Institute of Infectious Diseases as potential treatment for SARS-CoV-2
On Mar. 9, 2020, AIM ImmunoTech announced that the National Institute of Infectious Diseases (NIID) in Japan will…
-
UTSW researchers and international collaborators found human protein that potently inhibits coronavirus
On Mar. 8, 2020, an international team of investigators reported finding a protein produced by the human immune…
-
Biotechnology | Disease | FDA | Therapeutics
The FDA approved new treatment for adults with Cushing’s disease
On Mar. 6, 2020, the U.S. Food and Drug Administration (FDA) approved Isturisa (osilodrostat) oral tablets for adults…
-
Government of Canada invested $27 million in Coronavirus research
On Mar. 6, 2020, to further contribute to global efforts to address the COVID-19 outbreak, Canada’s Minister of…
-
University of British Columbia researchers received $2.8 million in federal funding to help with global COVID-19 response
On Mar. 6, 2020, University of British Columbia (UBC) researchers Yue Qian, Dr. Richard Lester, Dr. Srinivas Murthy,…
-
Mount Sinai and Harbour BioMed collaborated to advance treatment of cancer and Coronavirus COVID-19
On Mar. 6, 2020, Mount Sinai Health System and Harbour BioMed (HBM) announced a multi-year, multifaceted collaboration to…
